Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK

Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604

Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK

Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604

Authors: PAZARES L KUNKA R DEMARIA D CASSIDY J ALDEN M BERANEK P KAYE S LITTLEFIELD D REILLY D DEPEE S WISSEL P TWELVES C ODWYER P

Citation: L. Pazares et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE NEW TOPOISOMERASEINHIBITOR GI147211 GIVEN AS A 72-H CONTINUOUS-INFUSION, British Journal of Cancer, 78(10), 1998, pp. 1329-1336

Authors: GERRITS CJH CREEMERS GJ SCHELLENS JHM WISSEL P PLANTING AST KUNKA R SELINGER K DEBOERDENNERT M MARIJNEN Y HARTEVELD M VERWEIJ J

Citation: Cjh. Gerrits et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE NEW TOPOISOMERASE-I INHIBITOR GI147211, USING A DAILY X 5 INTRAVENOUS ADMINISTRATION, British Journal of Cancer, 73(6), 1996, pp. 744-750

Authors: ODWYER P PASAREZ L KUNKA R DEMARIA D CASSIDY J KAYE S DEPEE S LITTLEFIELD D SELINGER K BERANEK P GRAHAM J WISSEL P

Citation: P. Odwyer et al., PHASE-I TRIAL OF THE TOPOISOMERASE-I INHIBITOR GG211 AS A 72-HOUR INFUSION, European journal of cancer, 31A, 1995, pp. 928-928